Applies to: oxycodone, methocarbamol
MONITOR: Central nervous system- and/or respiratory-depressant effects may be additively or synergistically increased in patients taking multiple drugs that cause these effects, especially in elderly or debilitated patients.
MANAGEMENT: During concomitant use of these drugs, patients should be monitored for potentially excessive or prolonged CNS and respiratory depression. Ambulatory patients should be counseled to avoid hazardous activities requiring mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 28 Apr 2010 • 1 answer
Posted 17 Aug 2012 • 1 answer
Posted 7 Dec 2012 • 3 answers
Posted 13 Feb 2013 • 1 answer
Posted 17 Oct 2014 • 4 answers